Author

S. E. Hickson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:long-read sequencing· 1 Organism:virus· 1

Frequent Co-Authors

B. L. Hurst· 1 shared E. Brekke· 1 shared G. W. Buchko· 1 shared I. A. Salukhe· 1 shared I. Salukhe· 1 shared J. Hyde· 1 shared J. J. Woodward· 1 shared J. K. Craig· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. L. Hurst

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

{-}{-}{-}{-}{-}{-}{-}{-}RNA structures within Venezuelan equine encephalitis virus E1 alter macrophage replication fitness and contribute to viral emergence

S. E. Hickson, J. Hyde

This study identifies RNA structures in the E1 gene of epizootic VEEV that alter macrophage replication fitness, suggesting RNA secondary structures contribute to viral emergence.

bioRxiv · Apr 9, 2024Microbiology

Sequence diversity in the 3' untranslated region of alphavirus modulates IFIT2-dependent restriction in a cell type-dependent manner

S. E. Hickson, E. Brekke, J. Schwerk, I. Salukhe, S. A. Zaver, J. J. Woodward, R. Savan, J. L. Hyde

This study shows that variability in the 3UTR of VEEV modulates IFIT2-dependent restriction, with differential sensitivity observed in vitro.

bioRxiv · Dec 10, 2021Microbiology

High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.

R. Choi, M. Zhou, R. Shek, J. W. Wilson, L. Tillery, J. K. Craig, I. A. Salukhe, S. E. Hickson, N. Kumar, R. M. James, G. W. Buchko, R. Wu, S. Huff, T.-T. Nguyen, B. L. Hurst, , W. C. Van Voorhis

The paper screens drug libraries to find inhibitors of SARS-CoV-2 nsp15 endoribonuclease, identifying Exebryl-1 as a potential antiviral compound.

bioRxiv · Jan 21, 2021Microbiology